Sarah is from Dunedin, New Zealand where she completed a Bachelor of Biomedical Sciences and a Master of Science in Biochemistry at the University of Otago. She became interested in the field of precision medicine during her final year of undergraduate study and decided to pursue this field in her Master’s research where she was supervised by Professor Parry Guilford. Having read about the VPCC Next Generation Precision Medicine program, Sarah was very keen to do a PhD with a direct translational impact. Sarah’s research investigates the genomic, transcriptomic and epigenomic characterisations of pre-clinical models, specifically in childhood brain tumours.  She hopes that precision medicine will become routine for the management of paediatric cancers, ultimately increasing survivorship and reducing the adverse effects of cancer treatments.